Access and Safety-The FDA Drug Approval Conundrum

被引：0
|
作者：
Good, Chester B. [1 ]
Peasah, Samuel K. [2 ]
机构：
[1] Univ Pittsburgh, Insurance Serv Div, UPMC Hlth Plan, 600 Grant St,Univ Dr C, Pittsburgh, PA 15219 USA
[2] Univ Pittsburgh, Ctr Value Based Pharm Initiat, Insurance Serv Div, UPMC Hlth Plan, Pittsburgh, PA USA
来源：
JAMA NETWORK OPEN | 2024年 / 7卷 / 07期
关键词：
D O I：
10.1001/jamanetworkopen.2024.19823
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] FDA shifts on rare-disease drug approval
    Jarvis, Lisa
    CHEMICAL & ENGINEERING NEWS, 2017, 95 (29) : 14 - 14
  • [42] Fda ends 2020 with high drug approval rate
    Challener, Cynthia
    Pharmaceutical Technology, 2021, 45 (01) : 26 - 29
  • [43] Collateral damage: the conundrum of drug safety
    E. A. M. Gale
    Diabetologia, 2009, 52 : 1975 - 1982
  • [44] FDA declines approval of testosterone drug for third time
    O'Hanlon, Leslie Harris
    LANCET DIABETES & ENDOCRINOLOGY, 2013, 1
  • [45] Alzheimer Drug Lecanemab Gains Traditional FDA Approval
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, : 495
  • [46] APPROVABLE LETTERS IN THE FDA NEW DRUG APPROVAL PROCESS
    RICHARD, BW
    ULCICKAS, M
    LASAGNA, L
    JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (08): : 680 - 684
  • [47] FDA ADVISORY COMMITTEES AND THE NEW DRUG APPROVAL PROCESS
    KAITIN, KI
    MELVILLE, A
    MORRIS, B
    JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (10): : 886 - 890
  • [48] FDA drug approval summary:: Erlotinib (Tarceva®) tablets
    Cohen, MH
    Johnson, JR
    Chen, YF
    Sridhara, R
    Pazdur, R
    ONCOLOGIST, 2005, 10 (07): : 461 - 466
  • [49] FAMVIR SHINGLES DRUG GETS US FDA APPROVAL
    不详
    EUROPEAN CHEMICAL NEWS, 1994, 62 (1626): : 31 - 31
  • [50] Clarifications regarding the authority and role of FDA in drug approval
    Cavaille-Coll, Marc W.
    Stein, Peter P.
    Corrigan-Curay, Jacqueline A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (04) : 1210 - 1211
12345